Ginkgo Bioworks Holdings, Inc. (DNA) vs Geron Corporation (GERN)
- Ginkgo Bioworks Holdings, Inc. DNA 10.27 −12.67%
- Geron Corporation GERN 1.17 −4.88%
Ginkgo Bioworks Holdings, Inc. and Geron Corporation are both Biotechnology companies. Ginkgo Bioworks Holdings, Inc. and Geron Corporation are of similar size ($791.9M and $790.2M). Geron Corporation grew revenue faster over the last twelve months: 24.4% against −37.0%. Geron Corporation has the higher net margin (−33.1% vs −219.6%) and the higher return on invested capital (−89.9% vs −161.9%). Across the 18 metrics below, Geron Corporation leads on 14 and Ginkgo Bioworks Holdings, Inc. on 4.
Valuation
Profitability
| Metric | DNA | GERN | Biotechnology median |
|---|---|---|---|
| Gross margin | 68.04% | 93.51% | 65.16% |
| Operating margin | (231.13%) | (25.31%) | 0.00% |
| Net margin | (219.60%) | (33.05%) | 0.00% |
| Free cash flow margin | (131.57%) | (56.10%) | 0.00% |
| Return on equity | (56.29%) | (28.28%) | (56.36%) |
| Return on assets | (26.19%) | (12.59%) | (48.04%) |
| Return on invested capital | (161.94%) | (89.85%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack